Due to the heterogeneity associated with ultrasound evaluation in PCOS, there has been growing interest in using AMH as a possible surrogate marker for ovarian morphology assessment (Dumont et al., 2015), because it is typically elevated in women with PCOS compared to normo-ovulatory women (Cook et al., 2002). The gene discussed is AMH; the disease is polycystic ovary syndrome.